EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
ramusmedical
Volume 15 Issue 4

Regenerative Medicine: Hype and Hope or Safety and Efficacy?

Regenerative medicine, and the underlying stem cell technology on which it is based, offer considerable hope to patients suffering from trauma and acute or chronic d...
24 January 2024 Volume 15 Issue 4 chronic disease | commercialisation
Continue Reading →
Volume 15 Issue 2

Comparing Treatment Performance through Evidence Synthesis

A Solution for Sparse Evidence, Heterogeneous Studies, and Disconnected Networks If there is a variety of treatment options in a specific disease area, decision-m...
6 July 2023 Volume 15 Issue 2 comparisons | decision-makers
Continue Reading →
news

Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated phase 1 safety and efficacy data for DS-8201, an investigational HER2-targeti...
24 January 2018 news ADC | data
Continue Reading →
news

ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study.  RADIANCE-HTN, ReCor's study of its Parad...
10 January 2018 news cohort | completion
Continue Reading →
news

Roche announces Phase III study results for the treatment of people with advanced kidney cancer

Roche has announced that the Phase III IMmotion151 study met its co-primary endpoint of investigator-assessed progression-free survival (PFS) and demonstrated that th...
13 December 2017 news chemotherapy | efficacy
Continue Reading →
news

Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety & Efficacy in Clinical Trials

Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a trans...
30 November 2017 news clinical | e-health
Continue Reading →
news

Summit completes initial dosing trials on Duchenne muscular dystrophy drug

Summit Therapeutics has completed the half-way stage of dosing of its Duchenne Muscular Dystrophy (DMD) candidate ezutromid in a 48-week phase 2 trial, dubbed PhaseOu...
22 November 2017 news approval | Duchenne
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte